Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes
NCT ID: NCT06600555
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2024-07-03
2032-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The possible surgical techniques are the same as those for bariatric surgery:
* Sleeve,
* Bypass,
* Gastric band, but the main goal is not weight loss, it is remission of type 2 diabetes. It is called metabolic surgery.
The ring technique (gastroplasty) is practiced less and less in France because it is less effective in weight loss and is responsible for major discomfort.
Currently, metabolic surgery is one of the recommendations but no study has compared the effectiveness of the techniques with each other. One or other of the techniques can be chosen according to the preferences of the surgeon, the patient, the center, etc. but this choice is not made objectively, in the absence of comparative data.
This study would like to follow up on patients for whom metabolic surgery has been proposed by the doctor,.
If the surgery is accepted, this study would like to improve knowledge of the effectiveness of the different techniques, and thus demonstrate which metabolic surgery technique is preferred in terms of effectiveness and safety.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolic Surgery; Gastric Bypass vs Sleeve Gastrectomy; Efects Over Type 2 DM With Bad Metabolic Control (MSO1CT)
NCT03891056
Surgical Techniques in Diabetes Mellitus-II and Obesity. Metabolic Surgery Study (MSS)
NCT02310555
Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery
NCT06192693
Comparative Effectiveness of Bariatric Surgery Versus Medical Management to Induce Diabetes Remission in Diabetic Patients With BMI 30-35
NCT01423877
Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)
NCT01353066
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
metabolic surgery with SLEEVE technique
metabolic surgery with SLEEVE technique
metabolic surgery with SLEEVE technique
metabolic surgery with BY-PASS technique
metabolic surgery with BY-PASS technique
metabolic surgery with BY-PASS technique
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
metabolic surgery with SLEEVE technique
metabolic surgery with SLEEVE technique
metabolic surgery with BY-PASS technique
metabolic surgery with BY-PASS technique
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* T2D patient, with individualized glycemic objectives not achieved, despite medical care, in particular diabetological and nutritional, also including adapted physical activity, well conducted according to current good practice recommendations, for at least twelve months
* BMI between 30 and 34.9 kg/m²
* patient well informed beforehand about metabolic surgery and the study
* multidisciplinary evaluation (including a diabetologist) and decision on medical treatment by CM (date prior to inclusion)
* medical assessment of an acceptable surgical risk
* patient affiliated to or beneficiary of a social security system
* patient having freely signed the written informed consent
Exclusion Criteria
* severe and unstabilized eating behavior disorders
* dependence on alcohol and licit and illicit psychoactive substances
* illnesses endangering life in the short and medium term
* contraindications to general anesthesia
* absence of identified prior medical care and foreseeable inability of the patient to participate in lifelong medical monitoring
* history of bariatric surgery
* pregnant or breastfeeding woman, or having a very long-term pregnancy plan short term (\< 2 years)
* adult patient under guardianship or curatorship
* patient deprived of liberty or under judicial decision
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Médipôle Lyon-Villeurbanne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medipole Lyon Villeurbanne
Villeurbanne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
laetitia paradisi
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHANGE metabolic surgery
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.